153 web-programmer-developer-"https:" "https:" "https:" "https:" "https:" "https:" "University of Kent" positions at Imperial College London in United Kingdom
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
challenges, from workforce planning to performance and development. You’ll create strong working relationships to support the business to access key people services within the central function. As the Head of
-
on the role please contact: Ramona Oana Dobrea, Hospitality Sales Development Manager by email – o.dobrea@Imperial.ac.uk . Closing Date: Midnight on Wednesday, 8 April 2026 Attached documents are available
-
This is an exciting opportunity to join the new GSK–Oxford–Imperial Modelling-Informed Medicine Centre (MiMeC) and develop imaging and airflow modelling research for early Chronic Obstructive
-
complex trial involving the deliberate administration of S. aureus to healthy volunteers - work that is essential for understanding immune interaction and advancing vaccine development. We are looking for a
-
You will engage in cutting-edge translational research that develops computational models for assessing cardiac biomechanics and for predicting outcomes in cardiac diseases. This includes (1) a
-
. Ability to quickly develop strong and effective working relationships with a diverse range of stakeholders, both internally and externally. The opportunity to continue your career at a world-leading
-
accumulation of antibiotic drugs, rendering many ineffective. Despite a renewed focus on AMR research, there is still limited understanding of how to develop antibiotics that can cross these membranes and
-
highly capable individual to develop new methods and characterisation tools to advance materials for photocatalysis and photoelectrochemistry. This includes their synthesis, characterisation, integration
-
that are key to growth and progression of ovarian carcinoma and that may be therapeutic targets. The postholder will carry out research programmes investigating the role of specific mutations of driving innate
-
immunotherapy compared to placebo, in reducing the risk of developing asthma in a cohort of infants aged 5-12 months. 434 participants will be recruited across 12 sites in the UK. The trial is currently in the